Cathay Biotech Inc Cash Flow-to-Debt Ratio
Cathay Biotech Inc cash flow-to-debt ratio. Cathay Biotech Inc (688065) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-66.22 Million could theoretically repay 0% of its total liabilities (CN¥2.23 Billion) in one year. Check 688065 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cathay Biotech Inc (2016–2024)
Cash flow-to-debt ratio of Cathay Biotech Inc from 2016 to 2024. Historical debt coverage capacity for Cathay Biotech Inc across 9 annual periods. Check how aggressively does Cathay Biotech Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Cathay Biotech Inc Cash Flow-to-Debt Ratio by Year (2016–2024)
Cathay Biotech Inc cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Cathay Biotech Inc. For the full cash flow conversion analysis, see 688065 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | CN¥820.93 Million | CN¥3.92 Billion | ▲ +49.3% |
| 2023 | 0.14x | CN¥569.45 Million | CN¥4.06 Billion | ▼ -51.3% |
| 2022 | 0.29x | CN¥803.67 Million | CN¥2.79 Billion | ▼ -26.7% |
| 2021 | 0.39x | CN¥594.18 Million | CN¥1.51 Billion | ▼ -50.3% |
| 2020 | 0.79x | CN¥514.96 Million | CN¥650.74 Million | ▲ +194.9% |
| 2019 | 0.27x | CN¥359.62 Million | CN¥1.34 Billion | ▲ +4490.8% |
| 2018 | -0.01x | CN¥-10.29 Million | CN¥1.68 Billion | ▼ -110.7% |
| 2017 | 0.06x | CN¥53.45 Million | CN¥936.58 Million | ▲ +119.5% |
| 2016 | -0.29x | CN¥-128.67 Million | CN¥439.21 Million | — |